Erasmus MC Biomedical Fund
6
9M
4
1
0.33
1
- Stages of investment
- Areas of investment
Summary
The venture was found in Europe in The Netherlands. The main department of described VC is located in the Rotterdam.
The standard case for the fund is to invest in rounds with 4 partakers. Despite the Erasmus MC Biomedical Fund, startups are often financed by Thuja Capital, KBC, Forbion Capital Partners. The meaningful sponsors for the fund in investment in the same round are Forbion Capital Partners, Thuja Capital, Omnes Capital. In the next rounds fund is usually obtained by Omnes Capital, Forbion Capital Partners, Thuja Capital.
The fund is constantly included in less than 2 deals per year. Comparing to the other companies, this Erasmus MC Biomedical Fund performs on 12 percentage points less the average number of lead investments. The higher amount of exits for fund were in 2017. The real fund results show that this VC is 3 percentage points less often commits exit comparing to other companies. The usual things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2009.
Among the various public portfolio startups of the fund, we may underline arGEN-X For fund there is a match between the location of its establishment and the land of its numerous investments - The Netherlands. Among the most successful fund investment fields, there are Clinical Trials, Therapeutics. Besides, a startup needs to be aged 2-3 years to get the investment from the fund.
Investor highlights
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 6
- Lead investments
- 1
- Exits
- 1
- Follow on index
- 0.33
- Investments by industry
- Biotechnology (4)
- Therapeutics (3)
- Clinical Trials (3)
- Health Care (2)
- Medical (2) Show 1 more
- Investments by region
-
- Netherlands (6)
- Peak activity year
- 2009
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 15
- Group Appearance index
- 0.83
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| arGEN-X | 10 Sep 2009 | Biotechnology, Therapeutics, Clinical Trials | Early Stage Venture | 13M | Rotterdam, Netherlands, South Holland |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.